Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial-Reference-Cited by-同舟云学术

Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial

Published:2003-06 Issue:11 Volume:17 Page:1355-1364
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Sandborn W. J.,Sands B. E.,Wolf D. C.,Valentine J. F.,Safdi M.,Katz S.,Isaacs K. L.,Wruble L. D.,Katz J.,Present D. H.,Loftus E. V.,Graeme-Cook F.,Odenheimer D. J.,Hanauer S. B.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2036.2003.01589.x/fullpdf

Reference19 articles.

1. Growth factors in inflammatory bowel disease;Beck;Inflamm Bowel Dis,1999

2. rHuKGF ameliorates symptoms in DSS and CD4(+)CD45RB(Hi) T cell transfer mouse models of inflammatory bowel disease;Byrne;Am J Physiol Gastrointest Liver Physiol,2002

3. Epidermal growth factor enemas are effective in the treatment of left-sided ulcerative colitis;Sinha;Gastroenterology,2001

4. Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humans;Sung;AAPS Pharmsci,2002

5. Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats;Han;Am J Physiol Gastrointest Liver Physiol,2000

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease;Nutrients;2023-10-24

2. From the updated landscape of the emerging biologics for IBDs treatment to the new delivery systems;Journal of Controlled Release;2023-09

3. Capsulized Fecal Microbiota Transplantation Induces Remission in Patients with Ulcerative Colitis by Gut Microbial Colonization and Metabolite Regulation;Microbiology Spectrum;2023-06-15

4. Prospective use of amniotic mesenchymal stem cell metabolite products for tissue regeneration;Journal of Biological Engineering;2023-02-09

5. International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients;Medicina;2023-01-16